It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: lovebeck
A controversial drug to treat low sexual desire in women won approval from U.S. health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting when taken with alcohol.
Moreover, the U.S. Food and Drug Administration said the first approved drug for the condition, to be sold under the brand name Addyi, will only be available through certified health care professionals and pharmacies due to its safety issues.
The drug has been nicknamed "female Viagra" in media reports, even though it does not work like Pfizer Inc's blockbuster Viagra pill for men that in 1998 became the first approved drug for erectile dysfunction.
Flibanserin needs to be taken every day. Unlike Viagra, which affects blood flow to the genitals, flibanserin works on the brain. It is similar to a class of drugs known as selective serotonin reuptake inhibitors, or SSRI's, that include antidepressants such as Prozac.
Umm, no. Just no.
originally posted by: tadaman
a reply to: lovebeck
Wow, what a civilization. It is so telling;
Instead of learning what your partner likes or what you can do to be more attractive, or where you can grow sexually....we take a head pill. Just wow
How about this, if you dont want sex.....you dont have to have any. If you do, then great, get some butt. Done.